UK Companies House feature
BIG HEALTH LTD
Profile
- Company number
- 06780612
- Status
- Active
- Incorporation
- 2008-12-29
- Last accounts made up
- 2024-12-31
- Account category
- GROUP
- Primary SIC
- 62012
Accounts
Pending extraction
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- UK-adopted international accounting standards
- Reporting scope
- Consolidated (group)
- Auditor
- PKF Littlejohn LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Material uncertainty disclosed
“We draw attention to Note 2.4 of the financial statements, which describes the basis of preparation and management's assessment of the Group and Company's ability to continue as a going concern. As stated in the note, subsequent to the balance sheet date, the Group's cash runway is expected to last into Q3 2025, and as a result, the Group is in the process of securing an external equity investment of approximately $15 million. A non-binding co-led term sheet from two investors has been signed in June 2025, with the transaction expected to close by 31 July 2025, subject to customary closing conditions. The proceeds from this investment are intended to support the Company's strategic growth initiatives and extend its operational cash runway. These conditions indicate that at date of the audit report, a material uncertainty exists that may cast significant doubt on the Company's ability to continue as a going concern.”
Subsidiaries
- Big Health Inc. · 100% held · USA · Development of software applications
Significant events
- “Received two novel FDA clearances for insomnia and anxiety treatments, and secured national Medicare reimbursement through new CMS-issued codes uniquely tailored to our products.”
- “Introduced Spark Direct as an extension of our product portfolio, offering support for the treatment of depression, already generating revenue through existing employer clients.”
- “A non-binding co-led investor term sheet for a minimum $15M investment was signed in June 2025, expected to close by end of July 2025, to support growth and extend cash runway.”
- “During the year, the exercise prices of 6,279,185 share options were repriced down to $0.52 (approximately to £0.41) to reflect the recent fall in the company's underlying value.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
1 active · 14 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BERMAN, Yael | Director | 2024-04-02 | Feb 1986 | American |
Show 14 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ATKINS, Betsy | Director | 2022-11-01 | 2025-06-20 |
| BRISBOURNE, Nicholas Gwyn | Director | 2013-09-04 | 2016-06-14 |
| CASSIDY, John | Director | 2022-01-04 | 2025-09-16 |
| CHENG, Isaac S. | Director | 2020-05-18 | 2022-01-04 |
| COLE, Alliott David | Director | 2016-06-22 | 2025-09-16 |
| DITTMER, Janke Jorn | Director | 2020-03-16 | 2025-09-16 |
| ESPIE, Colin Alexander, Professor | Director | 2012-09-27 | 2022-01-04 |
| GUPTA, Arun | Director | 2019-11-19 | 2025-07-30 |
| HAMES, Barry David, Dr | Director | 2008-12-29 | 2010-01-07 |
| HAMES, Peter Andrew | Director | 2010-01-01 | 2022-09-26 |
| RIMER, Neil Alexander | Director | 2013-09-04 | 2020-03-16 |
| ROCKETT, Elizabeth | Director | 2016-06-22 | 2022-05-18 |
| SHAH, Anand, Dr. | Director | 2022-01-04 | 2025-07-30 |
| TAYLOR, Robert Bruce | Director | 2012-09-27 | 2013-12-31 |
Ownership
Persons with significant control
Filing timeline
Last 20 of 153 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-01-22 | SH08 | capital | capital name of class of shares |
| 2026-01-09 | RESOLUTIONS | resolution | resolution |
| 2026-01-09 | RESOLUTIONS | resolution | resolution |
| 2026-01-06 | CS01 | confirmation-statement | confirmation statement with updates |
| 2025-12-19 | SH19 | capital | capital statement capital company with date currency figure |
| 2025-12-19 | RESOLUTIONS | resolution | resolution |
| 2025-12-19 | CAP-SS | insolvency | legacy |
| 2025-12-19 | SH20 | capital | legacy |
| 2025-10-17 | TM01 | officers | termination director company with name termination date |
| 2025-10-17 | TM01 | officers | termination director company with name termination date |
| 2025-10-17 | TM01 | officers | termination director company with name termination date |
| 2025-10-16 | SH01 | capital | capital allotment shares |
| 2025-09-24 | AA | accounts | accounts with accounts type group |
| 2025-08-01 | TM01 | officers | termination director company with name termination date |
| 2025-08-01 | TM01 | officers | termination director company with name termination date |
| 2025-07-30 | TM01 | officers | termination director company with name termination date |
| 2025-01-03 | CS01 | confirmation-statement | confirmation statement with updates |
| 2024-07-23 | AA | accounts | accounts with accounts type group |
| 2024-07-09 | SH01 | capital | capital allotment shares |
| 2024-04-04 | AP01 | officers | appoint person director company with name date |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory